secwatch / observer
8-K filed May 10, 2024, 7:59 PM ET CIK 0001906133
regulatory confidence high sentiment negative materiality 0.65

iCoreConnect Inc.: Nasdaq/NYSE listing notice — iCoreConnect receives Nasdaq deficiency notice after director resignation; cure period until May 2025

iCoreConnect Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

iCoreConnect Inc. received a nasdaq noncompliance notice notice regarding board independence (rules 5605, 5605(b)(1)(A), 5605(c)(4)).

Exchange
nasdaq
Notice
noncompliance notice
Deficiency
board independence
Rules
5605, 5605(b)(1)(A), 5605(c)(4)
Exact text from the filing
May 8, 2024, the Company received a written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”), indicating that, as a result of Mr. Gitto’s resignation from the Board and Audit Committee, the Company is not currently in compliance with Nasdaq Listing Rule 5605, which requires that (i) a majority of the Board be comprised of independent directors and (ii) the Audit Committee is comprised of at least three independent directors. The Company currently has four directors, only two of which qualify as independent directors. In addition, the Audit Committee currently is comprised of o
View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR
accession 0001477932-24-002686
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.